• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Opioids Page 2

Opioids

Categories:

Toolkits Awareness Days What's New in Viral Hepatitis Hep A Hep B Hep C Opioids COVID-19

June 7, 2021

What’s New in Viral Hepatitis – June 2021

May 19, 2021

Patient Perspective on the Challenges of Treatment Restrictions in Hepatitis C Care

Read More

May 19, 2021

Dr. Lesley Miller on the Impact of Hepatitis C Treatment Restrictions on Patient Care

Read More

May 19, 2021

CHLPI and NVHR on the State of Hepatitis C Treatment Restrictions

Read More

March 25, 2021

Dr. Gregory Dore on Hepatitis C Treatment Barriers Among People Who Inject Drugs

Read More

March 18, 2021

Injection Drug Use and Hepatitis C Trends in the Indian Health Service

Read More

March 8, 2021

Dr. Judith Feinberg on Hepatitis C in Appalachia

Read More

February 26, 2021

What’s New in Viral Hepatitis – February 2021

Read More

February 9, 2021

Frank Hood on the Importance of Funding Viral Hepatitis Elimination

Read More

January 12, 2021

Viral Hepatitis National Strategic Plan: A Roadmap to Elimination 2021-2025

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.